Position in ABSI
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,013,532
-$175,209 QoQ
Shares Held
337,844
-0.8% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 96.60494192585928.ToString("F0")%
Shared 0.ToString("F0")%
None 3.395058074140728.ToString("F0")%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,649,111 across 269 Biotechnology names. ABSI ranks #168 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in ABSI
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,013,532 | 337,844 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,188,741 | 340,614 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,010,254 | 332,321 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $725,940 | 282,468 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $561,477 | 223,697 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $583,378 | 222,664 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $855,705 | 224,007 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $880,152 | 285,764 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $261,376 | 46,017 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $307,771 | 73,279 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $81,642 | 61,850 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $95,729 | 62,980 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $297,763 | 170,151 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $361,620 | 172,200 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $545,386 | 174,245 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $418,454 | 126,041 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,170,276 | 138,823 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $238,291 | 29,060 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $302,100 | 25,976 | Shares | Defined | 2021-11-18 | |
| No filing history on record for this holder in this stock. | ||||||